{"entity":{"type":"insider","cik":"0001479788","url":"/insider/0001479788","json_url":"/insider/0001479788.json","name":"Finn John","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":31,"n_filings":26,"first":"2011-02-22","last":"2013-07-23","span_basis":"filed_date"},"name_variants":[{"name":"Finn John","source":"filing","n_filings":26,"first_seen":"2011-02-22","last_seen":"2013-07-23"}],"transactions":[{"id":4940167,"accession":"0001209191-13-037588","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-037588","line_url":"/filing/0001209191-13-037588#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001479788","owner_name":"Finn John","owner_display_name":"Finn John","owner_url":"/insider/0001479788","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":12.1,"price_display":"12.10","price_state":"stated","total_value":12100.0,"total_display":"12,100.00","total_whole":"12,100","shares_owned_after":166860.0,"shares_owned_after_display":"166,860","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-07-22","filed_date":"2013-07-23","scope":"insider"},{"id":4565837,"accession":"0001209191-13-036879","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-036879","line_url":"/filing/0001209191-13-036879#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001479788","owner_name":"Finn John","owner_display_name":"Finn John","owner_url":"/insider/0001479788","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":10.55,"price_display":"10.55","price_state":"stated","total_value":36925.0,"total_display":"36,925.00","total_whole":"36,925","shares_owned_after":167860.0,"shares_owned_after_display":"167,860","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-07-15","filed_date":"2013-07-16","scope":"insider"},{"id":4756184,"accession":"0001209191-13-036534","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-13-036534","line_url":"/filing/0001209191-13-036534#line-3","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001479788","owner_name":"Finn John","owner_display_name":"Finn John","owner_url":"/insider/0001479788","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":10.1,"price_display":"10.10","price_state":"stated","total_value":50500.0,"total_display":"50,500.00","total_whole":"50,500","shares_owned_after":171360.0,"shares_owned_after_display":"171,360","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-07-12","filed_date":"2013-07-12","scope":"insider"},{"id":4756180,"accession":"0001209191-13-036534","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-036534","line_url":"/filing/0001209191-13-036534#line-2","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001479788","owner_name":"Finn John","owner_display_name":"Finn John","owner_url":"/insider/0001479788","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":9.32,"price_display":"9.32","price_state":"stated","total_value":4660.0,"total_display":"4,660.00","total_whole":"4,660","shares_owned_after":176360.0,"shares_owned_after_display":"176,360","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-07-11","filed_date":"2013-07-12","scope":"insider"},{"id":4756175,"accession":"0001209191-13-036534","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-036534","line_url":"/filing/0001209191-13-036534#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001479788","owner_name":"Finn John","owner_display_name":"Finn John","owner_url":"/insider/0001479788","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":8.58,"price_display":"8.58","price_state":"stated","total_value":8580.0,"total_display":"8,580.00","total_whole":"8,580","shares_owned_after":176860.0,"shares_owned_after_display":"176,860","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-07-10","filed_date":"2013-07-12","scope":"insider"},{"id":4790120,"accession":"0001209191-13-031938","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-031938","line_url":"/filing/0001209191-13-031938#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001479788","owner_name":"Finn John","owner_display_name":"Finn John","owner_url":"/insider/0001479788","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":9.0833,"price_display":"9.08","price_state":"stated","total_value":27249.9,"total_display":"27,249.90","total_whole":"27,250","shares_owned_after":177860.0,"shares_owned_after_display":"177,860","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-06-12","filed_date":"2013-06-12","scope":"insider"},{"id":4565263,"accession":"0001209191-13-031713","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-031713","line_url":"/filing/0001209191-13-031713#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001479788","owner_name":"Finn John","owner_display_name":"Finn John","owner_url":"/insider/0001479788","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":8.94,"price_display":"8.94","price_state":"stated","total_value":8940.0,"total_display":"8,940.00","total_whole":"8,940","shares_owned_after":180860.0,"shares_owned_after_display":"180,860","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-06-11","filed_date":"2013-06-11","scope":"insider"},{"id":5186219,"accession":"0001209191-13-026744","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-026744","line_url":"/filing/0001209191-13-026744#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001479788","owner_name":"Finn John","owner_display_name":"Finn John","owner_url":"/insider/0001479788","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":8.1024,"price_display":"8.10","price_state":"stated","total_value":40512.0,"total_display":"40,512.00","total_whole":"40,512","shares_owned_after":181860.0,"shares_owned_after_display":"181,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-14","filed_date":"2013-05-16","scope":"insider"},{"id":9268648,"accession":"0001209191-13-031712","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-031712","line_url":"/filing/0001209191-13-031712#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001479788","owner_name":"Finn John","owner_display_name":"Finn John","owner_url":"/insider/0001479788","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":7.475,"price_display":"7.48","price_state":"stated","total_value":22425.0,"total_display":"22,425.00","total_whole":"22,425","shares_owned_after":186860.0,"shares_owned_after_display":"186,860","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-05-10","filed_date":"2013-06-11","scope":"insider"},{"id":5510598,"accession":"0001209191-13-025754","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-025754","line_url":"/filing/0001209191-13-025754#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001479788","owner_name":"Finn John","owner_display_name":"Finn John","owner_url":"/insider/0001479788","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":7.475,"price_display":"7.48","price_state":"stated","total_value":22425.0,"total_display":"22,425.00","total_whole":"22,425","shares_owned_after":186860.0,"shares_owned_after_display":"186,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-10","filed_date":"2013-05-13","scope":"insider"},{"id":5358264,"accession":"0001181431-13-023616","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-023616","line_url":"/filing/0001181431-13-023616#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001479788","owner_name":"Finn John","owner_display_name":"Finn John","owner_url":"/insider/0001479788","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":7.1,"price_display":"7.10","price_state":"stated","total_value":3550.0,"total_display":"3,550.00","total_whole":"3,550","shares_owned_after":189860.0,"shares_owned_after_display":"189,860","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-24","filed_date":"2013-04-26","scope":"insider"},{"id":5291335,"accession":"0001181431-13-017383","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-017383","line_url":"/filing/0001181431-13-017383#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001479788","owner_name":"Finn John","owner_display_name":"Finn John","owner_url":"/insider/0001479788","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":7.1,"price_display":"7.10","price_state":"stated","total_value":10650.0,"total_display":"10,650.00","total_whole":"10,650","shares_owned_after":190360.0,"shares_owned_after_display":"190,360","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-03-15","filed_date":"2013-03-18","scope":"insider"},{"id":9061782,"accession":"0001181431-11-052581","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-052581","line_url":"/filing/0001181431-11-052581#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001479788","owner_name":"Finn John","owner_display_name":"Finn John","owner_url":"/insider/0001479788","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":6.19,"price_display":"6.19","price_state":"stated","total_value":3095.0,"total_display":"3,095.00","total_whole":"3,095","shares_owned_after":171860.0,"shares_owned_after_display":"171,860","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-10-11","filed_date":"2011-10-12","scope":"insider"},{"id":9171816,"accession":"0001181431-11-049533","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-049533","line_url":"/filing/0001181431-11-049533#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001479788","owner_name":"Finn John","owner_display_name":"Finn John","owner_url":"/insider/0001479788","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":6.47,"price_display":"6.47","price_state":"stated","total_value":6470.0,"total_display":"6,470.00","total_whole":"6,470","shares_owned_after":172360.0,"shares_owned_after_display":"172,360","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-09-15","filed_date":"2011-09-16","scope":"insider"},{"id":8865222,"accession":"0001181431-11-045356","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-045356","line_url":"/filing/0001181431-11-045356#line-2","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001479788","owner_name":"Finn John","owner_display_name":"Finn John","owner_url":"/insider/0001479788","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":2100.0,"total_display":"2,100.00","total_whole":"2,100","shares_owned_after":173360.0,"shares_owned_after_display":"173,360","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-08-12","filed_date":"2011-08-12","scope":"insider"},{"id":8865220,"accession":"0001181431-11-045356","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-045356","line_url":"/filing/0001181431-11-045356#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001479788","owner_name":"Finn John","owner_display_name":"Finn John","owner_url":"/insider/0001479788","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":1400.0,"total_display":"1,400.00","total_whole":"1,400","shares_owned_after":173660.0,"shares_owned_after_display":"173,660","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-08-11","filed_date":"2011-08-12","scope":"insider"},{"id":9141454,"accession":"0001181431-11-044768","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-044768","line_url":"/filing/0001181431-11-044768","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001479788","owner_name":"Finn John","owner_display_name":"Finn John","owner_url":"/insider/0001479788","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":5.964,"price_display":"5.96","price_state":"stated","total_value":5964.0,"total_display":"5,964.00","total_whole":"5,964","shares_owned_after":173860.0,"shares_owned_after_display":"173,860","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-08-09","filed_date":"2011-08-10","scope":"insider","n_lines":2},{"id":8880833,"accession":"0001181431-11-041909","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-041909","line_url":"/filing/0001181431-11-041909#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001479788","owner_name":"Finn John","owner_display_name":"Finn John","owner_url":"/insider/0001479788","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":4000.0,"total_display":"4,000.00","total_whole":"4,000","shares_owned_after":174860.0,"shares_owned_after_display":"174,860","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-07-20","filed_date":"2011-07-21","scope":"insider"},{"id":8825429,"accession":"0001181431-11-041061","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-041061","line_url":"/filing/0001181431-11-041061#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001479788","owner_name":"Finn John","owner_display_name":"Finn John","owner_url":"/insider/0001479788","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":7.2304,"price_display":"7.23","price_state":"stated","total_value":10845.6,"total_display":"10,845.60","total_whole":"10,846","shares_owned_after":175360.0,"shares_owned_after_display":"175,360","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-07-12","filed_date":"2011-07-13","scope":"insider"},{"id":9044246,"accession":"0001181431-11-036098","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-036098","line_url":"/filing/0001181431-11-036098#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001479788","owner_name":"Finn John","owner_display_name":"Finn John","owner_url":"/insider/0001479788","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":8.094,"price_display":"8.09","price_state":"stated","total_value":16188.0,"total_display":"16,188.00","total_whole":"16,188","shares_owned_after":176860.0,"shares_owned_after_display":"176,860","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-06-09","filed_date":"2011-06-10","scope":"insider"},{"id":9178620,"accession":"0001181431-11-030328","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-030328","line_url":"/filing/0001181431-11-030328#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001479788","owner_name":"Finn John","owner_display_name":"Finn John","owner_url":"/insider/0001479788","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":8.0233,"price_display":"8.02","price_state":"stated","total_value":56163.1,"total_display":"56,163.10","total_whole":"56,163","shares_owned_after":178860.0,"shares_owned_after_display":"178,860","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-05-16","filed_date":"2011-05-17","scope":"insider"},{"id":8924833,"accession":"0001181431-11-029564","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-029564","line_url":"/filing/0001181431-11-029564#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001479788","owner_name":"Finn John","owner_display_name":"Finn John","owner_url":"/insider/0001479788","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":10500.0,"total_display":"10,500.00","total_whole":"10,500","shares_owned_after":185860.0,"shares_owned_after_display":"185,860","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-05-12","filed_date":"2011-05-13","scope":"insider"},{"id":9171471,"accession":"0001181431-11-028649","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-028649","line_url":"/filing/0001181431-11-028649#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001479788","owner_name":"Finn John","owner_display_name":"Finn John","owner_url":"/insider/0001479788","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":6.018,"price_display":"6.02","price_state":"stated","total_value":6018.0,"total_display":"6,018.00","total_whole":"6,018","shares_owned_after":187360.0,"shares_owned_after_display":"187,360","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-05-10","filed_date":"2011-05-10","scope":"insider"},{"id":9131469,"accession":"0001181431-11-027035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-027035","line_url":"/filing/0001181431-11-027035#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001479788","owner_name":"Finn John","owner_display_name":"Finn John","owner_url":"/insider/0001479788","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":4800.0,"total_display":"4,800.00","total_whole":"4,800","shares_owned_after":188360.0,"shares_owned_after_display":"188,360","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-05-03","filed_date":"2011-05-04","scope":"insider"},{"id":9014843,"accession":"0001181431-11-023639","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-023639","line_url":"/filing/0001181431-11-023639#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001479788","owner_name":"Finn John","owner_display_name":"Finn John","owner_url":"/insider/0001479788","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":5.356,"price_display":"5.36","price_state":"stated","total_value":2678.0,"total_display":"2,678.00","total_whole":"2,678","shares_owned_after":189160.0,"shares_owned_after_display":"189,160","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-04-11","filed_date":"2011-04-12","scope":"insider"},{"id":9034400,"accession":"0001181431-11-021054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-021054","line_url":"/filing/0001181431-11-021054#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001479788","owner_name":"Finn John","owner_display_name":"Finn John","owner_url":"/insider/0001479788","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":1200.0,"total_display":"1,200.00","total_whole":"1,200","shares_owned_after":189660.0,"shares_owned_after_display":"189,660","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-03-30","filed_date":"2011-03-31","scope":"insider"},{"id":9079523,"accession":"0001181431-11-017160","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-017160","line_url":"/filing/0001181431-11-017160#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001479788","owner_name":"Finn John","owner_display_name":"Finn John","owner_url":"/insider/0001479788","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":5.86,"price_display":"5.86","price_state":"stated","total_value":2930.0,"total_display":"2,930.00","total_whole":"2,930","shares_owned_after":189860.0,"shares_owned_after_display":"189,860","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-03-09","filed_date":"2011-03-10","scope":"insider"},{"id":9014662,"accession":"0001181431-11-014956","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-014956","line_url":"/filing/0001181431-11-014956#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001479788","owner_name":"Finn John","owner_display_name":"Finn John","owner_url":"/insider/0001479788","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":3500.0,"total_display":"3,500.00","total_whole":"3,500","shares_owned_after":190360.0,"shares_owned_after_display":"190,360","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-03-01","filed_date":"2011-03-03","scope":"insider"},{"id":8924166,"accession":"0001181431-11-011820","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-011820","line_url":"/filing/0001181431-11-011820#line-2","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001479788","owner_name":"Finn John","owner_display_name":"Finn John","owner_url":"/insider/0001479788","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":3000.0,"total_display":"3,000.00","total_whole":"3,000","shares_owned_after":190860.0,"shares_owned_after_display":"190,860","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-02-18","filed_date":"2011-02-22","scope":"insider"},{"id":8924163,"accession":"0001181431-11-011820","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-011820","line_url":"/filing/0001181431-11-011820#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001479788","owner_name":"Finn John","owner_display_name":"Finn John","owner_url":"/insider/0001479788","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":2500.0,"total_display":"2,500.00","total_whole":"2,500","shares_owned_after":191360.0,"shares_owned_after_display":"191,360","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-02-17","filed_date":"2011-02-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":31,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":31,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":31},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001356857","name":"Trius Therapeutics Inc","url":"/issuer/0001356857","role":"Officer (Chief Scientific Officer)","n_filings":26,"first_seen":"2011-02-22","last_seen":"2013-07-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001479788","retrieved_at":"2026-08-24T10:49:26+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}